Fulgent Genetics Inc expected to post a loss of 56 cents a share - Earnings Preview

Fulgent Genetics

25/02/2023 03:11

* Fulgent Genetics Inc  FLGT.OQ   FLGT.O  is expected
to show a
fall in quarterly revenue when it reports  results on February
28. 
    * The Temple City California-based  company is expected to
report 
a 76.3% decrease in revenue to $59.569 million from $251.67
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. The company's guidance on
November 7 2022, for the period ended December 31, was for
revenue of $52.000 million.
    * ​Refinitiv's mean analyst estimate for Fulgent Genetics
Inc is
for a loss of 56 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Fulgent
Genetics
Inc is $45​, above​ its last closing price of $31.50. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  0.05        0.05       0.32      Beat    498.1
 Jun. 30 2022  0.73        0.73       0.78      Beat    6.8
 Mar. 31 2022  3.84        3.86       5.08      Beat    31.6​
 Dec. 31 2021  2.61        2.61       3.34      Beat    28.1
 ​​Sep.        3.25        3.25       3.95      Beat    21.7
 30 2021                                                
 Jun. 30 2021  2.78        2.76       2.47      Missed  -10.4​
 Mar. 31 2021  5.82        5.86       6.59      Beat    12.5
 Dec. 31 2020  4.30        4.05       6.20      Beat    52.9
 This summary was machine generated February 25 at 03:10 GMT. 
All figures in US dollars  unless otherwise stated